{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T07:02:11Z","timestamp":1772953331141,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.msard.2021.103463","type":"journal-article","created":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T22:01:14Z","timestamp":1639605674000},"page":"103463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Prodromal emesis in MOG-antibody associated disorder"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8899-8578","authenticated-orcid":false,"given":"M.","family":"Netravathi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikram Venkappayya","family":"Holla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jitender","family":"Saini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Mahadevan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.msard.2021.103463_bib0020","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1474-4422(19)30488-0","article-title":"Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicenter observational study","volume":"19","author":"Armangue","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2021.103463_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.101965","article-title":"Prodromal headache in MOG-antibody positive ON","volume":"40","author":"Asseyer","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2021.103463_bib0021","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1177\/1352458516631038","article-title":"Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): extending the spectrum of MOG antibody positive diseases","volume":"22","author":"Baumann","year":"2016","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2021.103463_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102308","article-title":"Anti-MOG associated disease masquerading as prolonged intractable nausea and vomiting","volume":"44","author":"Block","year":"2020","journal-title":"Mult. Scler. Relat. disord."},{"key":"10.1016\/j.msard.2021.103463_bib0018","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/j.1536-4801.2004.tb00878.x","article-title":"Vomiting & gastroparesis in thoracic myelopathy with pure sympathetic dysfunction","volume":"39","author":"Chelimsky","year":"2002","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.msard.2021.103463_bib0014","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3389\/fneur.2020.00396","article-title":"Value of area postrema syndrome in differentiating adults with AQP4 vs. MOG Antibodies","volume":"11","author":"Hyun","year":"2020","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2021.103463_bib0008","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12974-016-0719-z","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: brainstem involvement - frequency, presentation, and outcome","volume":"13","author":"Jarius","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.msard.2021.103463_bib0010","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1093\/brain\/awx276","article-title":"Clinical presentation and prognosis in MOGAD: a UK study","volume":"140","author":"Juryncczyk","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.msard.2021.103463_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.0000000000008786","article-title":"Does area postrema syndrome occur in myelin oligodendrocyte glycoprotein-IgG-associated disorders (MOGAD)?","volume":"94","author":"Kunchok","year":"2020","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2021.103463_bib0001","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1177\/1352458519868796","article-title":"MOG-antibody-associated disease is different from MS and NMOSD and should be considered as a distinct disease entity \u2013 yes","volume":"26","author":"Leite","year":"2020","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2021.103463_bib0022","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s00415-018-8956-y","article-title":"Myelin oligodendrocyte glycoprotein-positive optic neuritis masquerading as pseudotumor cerebri at presentation","volume":"265","author":"Lotan","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2021.103463_bib0005","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1742-2094-8-184","article-title":"Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders","volume":"8","author":"Mader","year":"2011","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.msard.2021.103463_bib0017","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s10072-020-04892-7","article-title":"Anti-MOG associated demyelinating disorders: two sides of same coin","volume":"42","author":"Maniscalco","year":"2021","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.msard.2021.103463_bib0024","first-page":"1","article-title":"Distinctive lesions of brain MRI between MOG-antibody associated and AQP4-antibody associated diseases","volume":"0","author":"Matsumato","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"9","key":"10.1016\/j.msard.2021.103463_bib0012","first-page":"515","article-title":"Worsening nausea, vomiting and dizziness: case report","volume":"68","author":"Murphy","year":"2019","journal-title":"J. Fam. Pract."},{"key":"10.1016\/j.msard.2021.103463_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.05.001","article-title":"MOG antibody seropositive aseptic meningitis: a new clinical phenotype","volume":"333","author":"Nagabushana","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2021.103463_bib0006","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.msard.2019.01.032","article-title":"Clinical, neuroimaging and therapeutic response in AQP4-positive NMO patients from India","volume":"30","author":"Netravathi","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2021.103463_bib0002","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00415-020-10300-z","article-title":"Myelin oligodendrocyte glycoprotein\u2011antibody\u2011associated disorder: a new inflammatory CNS demyelinating disorder","volume":"268","author":"Netravathi","year":"2021","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2021.103463_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/01658107.2012.738759","article-title":"Magnetic resonance imaging findings of elevated intracranial pressure in cerebral venous thrombosis versus idiopathic intracranial hypertension with transverse sinus stenosis","volume":"37","author":"Ridha","year":"2013","journal-title":"Neuroophthalmology"},{"issue":"6","key":"10.1016\/j.msard.2021.103463_bib0007","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","article-title":"Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders","volume":"11","author":"Sato","year":"2014","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2021.103463_bib0003","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"04","key":"10.1016\/j.msard.2021.103463_bib0009","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-0036-1583184","article-title":"Myelin oligodendrocyte glycoprotein-associated pediatric central nervous system demyelination: clinical course, neuroimaging findings, and response to therapy","volume":"47","author":"Thulasirajah","year":"2016","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.msard.2021.103463_bib0004","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2021.103463_bib0011","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3389\/fneur.2019.00415","article-title":"Seizure and myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis in a retrospective cohort of Chinese patients","volume":"10","author":"Zhong","year":"2019","journal-title":"Front. Neurol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482100729X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482100729X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:02:00Z","timestamp":1761901320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221103482100729X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":24,"alternative-id":["S221103482100729X"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2021.103463","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prodromal emesis in MOG-antibody associated disorder","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2021.103463","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103463"}}